Blood Cancer Talks
autor: Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
Episode 75. ASCO & EHA 2026 Myeloid Roundup with Dr. Joshua Zeidner
O tomto podcastu
This is a podcast on latest advances in the understanding and management of blood cancers. Here, we will bring a wide range of experts within hematologic malignancies to discuss various topics in depth.
Host: Raj Chakraborty, MD from Columbia University, New York, Ashwin Kishtagari, MD, from Vanderbilt University, Nashville, and Edward Cliff, MD, from Harvard University, Boston
Tweet your suggestions and feedback to @rajshekharucms @AshKishtagari @Eddie_Cliff @BloodCancerTalk
Epizody
Nejnovějších 20 z 76 epizod
- Episode 75. ASCO & EHA 2026 Myeloid Roundup with Dr. Joshua Zeidner · 57 min · Epizoda 76Topics Covered 1. KOMET-007 and SNDX-5613-0708: Menin Inhibitors with Intensive Chemotherapy KOMET-007: Phase 1a/b study adding ziftomenib 600 mg once daily, starting on day 8…
- Episode 74. Myeloma Updates from ASCO/EHA 2026 with Dr. Prashant Kapoor · 58 min · Epizoda 75Blood Cancer Talks — Show Notes Episode: Best of ASCO/EHA 2026 — Multiple Myeloma & AL Amyloidosis Guest: Dr. Prashant Kapoor, MD Professor of Medicine, Mayo Clinic, Rochester…
- Episode 73. ASCO and EHA 2026 Lymphoma Roundup with Dr. Thomas Lew · 46 min · Epizoda 74BloodCancerTalks: ASCO/EHA 2026 Lymphoma Round-Up with Dr. Thomas Lew Guest: Dr. Thomas Lew, Peter MacCallum Cancer Centre (Melbourne, Australia) — hematologist specializing in…
- Episode 72. frontMIND Trial in DLBCL with Dr. Charles Herbaux · 41 min · Epizoda 73Episode Overview For the second time in two decades, a phase 3 trial has shown a statistically significant improvement over R-CHOP in newly diagnosed diffuse large B-cell…
- Episode 71. Management of Newly Diagnosed Multiple Myeloma with Dr. Vincent Rajkumar · 52 min · Epizoda 72In this episode, Raj, Ashwin, and Eddie sit down with Dr. Vincent Rajkumar — Professor of Medicine at Mayo Clinic and Chair of the ECOG Myeloma Committee — for a clinically…
- Episode 70. ASH 2025 Myeloid Neoplasm Roundup with Dr. Curtis Lachowiez · 57 min · Epizoda 71In this episode, we dive deep into ASH 2025 updates on myeloid malignancies with Dr. Curtis Lachowiez. From the plenary halls of ASH 2025 to long-term follow-up of…
- Episode 69. ASH 2025 Lymphoma Roundup with Dr. Carla Casulo · 44 min · Epizoda 70BloodCancerTalks: ASH 2025 Lymphoma Roundup Guest: Dr. Carla Casulo, Associate Professor, Wilmot Cancer Centre, University of Rochester Abstracts Discussed Follicular Lymphoma…
- Episode 68. ASH 2025 Myeloma Special: MajesTEC-3 and the Bispecific Revolution with Dr. Luciano Costa · 46 min · Epizoda 69Join hosts Raj, Ashwin, and Eddie in this episode of Blood Cancer Talks as they welcome Dr. Luciano Costa, the first author of the NEJM manuscript on the MajesTEC-3 RCT, which…
- Episode 67. Management of CMV in Hematologic Malignancies · 40 min · Epizoda 68Join hosts Eddie, Ashwin, and Raj as they welcome Dr. Michelle Yong and Dr. Gemma Reynolds, academic infectious diseases physicians from the Peter MacCallum Cancer Centre and the…
- Episode 66. International Myeloma Society 2025 Annual Meeting Updates with Dr. Alfred Garfall: The Bispecific Bonanza · 52 min · Epizoda 67This episode provides comprehensive coverage of key clinical trial updates from the 2025 International Myeloma Society (IMS) Annual Meeting in Toronto, with special focus on…
- Episode 65. Circulating Tumor DNA in DLBCL with Dr. Ash Alizadeh and Dr. David Russler-Germain · 53 min · Epizoda 66In this episode of Blood Cancer Talks, hosts Eddie, Ashwin, and Raj welcome two distinguished experts to explore the cutting-edge field of circulating tumor DNA (ctDNA) in B-cell…
- Episode 64. Lymphoma Updates from EHA and ICML 2025 with Dr. Adrian Minson · 43 min · Epizoda 65In this episode of Blood Cancer Talks, we have Dr. Adrian Minson from the Peter MacCallum Cancer Centre to discuss the latest developments in lymphoma presented at the recent EHA…
- Episode 63. Management of Follicular Lymphoma with Dr. Gilles Salles · 52 min · Epizoda 64In this episode, we discuss the management of follicular lymphoma with Dr. Gilles Salles from Memorial Sloan Kettering Cancer Center. Here are the articles we discussed: 1…
- Episode 62. Unpacking MIDAS Trial in Myeloma with Dr. Meera Mohan · 25 min · Epizoda 63In this episode, we dissect the phase 3 MIDAS trial in newly diagnosed transplant-eligible multiple myeloma with Dr. Meera Mohan. https://pubmed.ncbi.nlm.nih.gov/39841461/…
- Episode 61. Menin Inhibitors in AML with Dr. Eytan Stein · 56 min · Epizoda 62In this episode, we took a deep dive intro the landscape of menin inhibitors in AML with Dr. Eytan Stein from MSKCC. Here are the key trials and studies we discussed: • ELN 2022…
- Episode 60. Emergency Podcast-AQUILA and STARGLO · 55 min · Epizoda 61In this episode, we discuss the recent proceedings at the FDA ODAC meeting on AQUILA trial in smoldering myeloma and STRAGLO in R/R DLBCL, and provide an update to our audience…
- Episode 59. Management of Systemic Mastocytosis with Dr. Daniel DeAngelo · 1 h 3 min · Epizoda 60In this episode, we discussed the management of systemic mastocytosis with Dr. Daniel DeAngelo from the Dana Farber Cancer Institute. Here are the key studies we discussed: •…
- Episode 58: CAR Transgenic T-cell Lymphoproliferative Neoplasms (CTTLN) with Dr. Piers Blombery · 50 min · Epizoda 59In this episode, we explore the emerging entity of CAR Transgenic T-cell Lymphoproliferative Neoplasms (CTTLN), a rare but important complication of CAR T-cell therapy. Dr. Piers…
- Episode 57. ASH 2024 Update on Leukemia/Myeloid Neoplasms with Dr. Jayastu Senapati · 55 min · Epizoda 58In this episode, we delve into the key clinically relevant abstracts in leukemia and myeloid neoplasms with Dr. Jayastu Senapati from the MD Anderson Cancer Center. Here are the…
- Episode 56. Management of Newly Diagnosed CML with Dr. Hagop Kantarjian · 1 h 2 min · Epizoda 57In this episode, we discuss the management of CML with Dr. Hagop Kantarjian from MD Anderson Cancer Center. Here are the key articles we discussed: 1. ASC4FIRST RCT: Asciminib…








